Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
113 participants
INTERVENTIONAL
2008-07-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Three Soft Bifocal Contact Lenses
NCT00808340
Handling Comparison Between Two Contact Lens Types
NCT02310126
Evaluation of an Investigational Multifocal Lens
NCT02223754
Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population
NCT01763047
Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses
NCT02956460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
senofilcon A / balafilcon A
senofilcon A multifocal lenses worn first, balafilcon A multifocal lenses worn second
balafilcon A
multifocal contact lens
senofilcon A
multifocal contact lens
balafilcon A/senofilcon A
balafilcon A multifocal lenses worn first, senofilcon A multifocal lenses worn second
balafilcon A
multifocal contact lens
senofilcon A
multifocal contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
balafilcon A
multifocal contact lens
senofilcon A
multifocal contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject must have presbyopic symptoms or be already wearing presbyopic contact lens correction.
* The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 or -9.00 to -10.00 in each eye.
* Refractive cylinder must be -0.75 D in each eye.
* The subject must have an ADD power of +0.75D to +2.50D in each eye.
* The subject must have best corrected visual acuity of 20/20-3 or better in each eye
* The subject's must have at least 20/30-distance vision OU with the study contact lenses.
* The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses
* The subject must be an adapted soft contact lens wearer in both eyes.
* The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
* The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.
Exclusion Criteria
* Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
* Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear
* Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
* Any ocular infection.
* Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
* Pregnancy or lactation
* Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
* History of diabetes
* History of binocular vision abnormality or strabismus
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. James Weber & Associates
Jacksonville, Florida, United States
Ted Brink & Associates
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Eye Associates of Winter Park
Winter Park, Florida, United States
Lee Rigel
East Lansing, Michigan, United States
Timothy R. Poling, OD
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-1485CK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.